JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 3 February 2006. doi:10.1136/jcp.2005.029876
Journal of Clinical Pathology 2006;59:460-467
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2005.029876v1
59/5/460    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voutilainen, K A
Right arrow Articles by Kosma, V-M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voutilainen, K A
Right arrow Articles by Kosma, V-M
Related Collections
Right arrow Histopathology
Right arrow Cancer: gynecological

ORIGINAL ARTICLE

Prognostic significance of E-cadherin–catenin complex in epithelial ovarian cancer

K A Voutilainen1, M A Anttila2, S M Sillanpää1, K M Ropponen1, S V Saarikoski2, M T Juhola3, V-M Kosma1

1 Department of Pathology and Forensic Medicine, University of Kuopio and Kuopio University Hospital, Kuopio, Finland
2 Department of Obstetrics and Gynaecology, Kuopio University Hospital
3 Department of Pathology, Jyväskylä Central Hospital, Jyväskylä, Finland

Correspondence to:
Dr V-M Kosma
Department of Pathology and Forensic Medicine, University of Kuopio and Kuopio University Hospital, PO Box 1627, FIN-70211 Kuopio, Finland; VeliMatti.Kosma{at}uku.fi Objective: To clarify the prognostic role of E-cadherin and ß- and {gamma}-catenins, and their relation to CD44 in epithelial ovarian carcinoma.

Methods: The expression of E-cadherin and ß- and {gamma}-catenins was analysed immunohistochemically in 305 primary epithelial ovarian cancers and 44 metastases, and related to CD44 expression, clinicopathological factors, and the patients’ survival.

Results: Reduced cell surface expression of E-cadherin, ß-catenin, and {gamma}-catenin was particularly frequent in serous and endometrioid histological types. Reduced cell surface expression of E-cadherin and ß-catenin was also associated with poor differentiation. Nuclear positivity of ß-catenin was associated with high CD44 expression, endometrioid histology, and local stage of the tumour, whereas nuclear {gamma}-catenin expression was associated with serous histology and poor differentiation. In the univariate analysis, preserved cell surface ß-catenin expression in the whole study material and nuclear expression of ß- and {gamma}-catenins in the subgroup of endometrioid ovarian cancers were predictors of better 10 year disease related survival. Preserved cell surface expression of E-cadherin and ß-catenin predicted favourable recurrence-free survival. These statistical significances were not retained in multivariate analysis.

Conclusions: The correlation between nuclear ß-catenin and CD44 indicates that ß-catenin may regulate the transcription of CD44 in epithelial ovarian cancer. E-cadherin–catenin complex members are associated with the prognosis of patients with epithelial ovarian cancer, but these univariate associations were not strong enough to compete for significance with the traditional clinicopathological factors.


Abbreviations: ABC, avidin-biotin-peroxidase complex; FIGO, International Federation of Gynecologists and Obstetricians

Keywords: E-cadherin; ß-catenin; {gamma}-catenin; ovarian carcinoma; survival




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
E. Baumgart, M. S. Cohen, B. S. Neto, M. A. Jacobs, C. Wotkowicz, K. M. Rieger-Christ, A. Biolo, R. Zeheb, M. Loda, J. A. Libertino, et al.
Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors
Clin. Cancer Res., March 15, 2007; 13(6): 1685 - 1694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.